Buprenorphine/naloxone - one formulation that doesn't fit all: a case report

Abstract Background Sublingual buprenorphine, approved for treatment of opioid use disorder since 2002, is most commonly available in co-formulation with naloxone. Naloxone is an opioid antagonist minimally absorbed when sublingual (SL) buprenorphine/naloxone is taken as prescribed; it is thought to...

Cur síos iomlán

Sábháilte in:
Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Hannan M. Braun (Údar), Jessica L. Taylor (Údar), Sarah Axelrath (Údar)
Formáid: LEABHAR
Foilsithe / Cruthaithe: BMC, 2024-07-01T00:00:00Z.
Ábhair:
Rochtain ar líne:Connect to this object online.
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Ar líne

Connect to this object online.

3rd Floor Main Library

Sonraí sealbhúcháin ó 3rd Floor Main Library
Gairmuimhir: A1234.567
Cóip 1 Ar fáil